Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / How Private Equity Is Consolidating Independent Dentists
Transcript
- Lucas: The numbers coming out of the dental consolidation space right now are frankly staggering. We are seeing Dental Service Organizations, or DSOs, acquiring independent practices at twenty times earnings in certain hot markets like Florida and Texas. That is not a typo. It is roughly double what a typical manufacturing roll-up pays today. Luna: Twenty times earnings? That sounds like pure speculation unless those practices have massive recurring revenue streams locked into insurance contracts. Lucas: Exactly. And that is the key distinction. These aren't just clinics pulling patients in off the street. They are bundling hundreds of locations to negotiate better rates with insurance payers and supply vendors. The scale creates margin that an independent dentist simply cannot match on their own. Luna: So it is less about clinical excellence and more about buying market share to squeeze suppliers and insurers. Lucas: Precisely. Let us look at the mechanics. A typical DSO acquires three to five practices a year. They bring in operational experts to handle billing, HR, and marketing. The dentist keeps their clinical license but hands over the business operations. In return, they get a guaranteed salary plus a percentage of the profits. Luna: That sounds appealing for someone who loves dentistry but hates running a business. Why would anyone resist that deal? Lucas: Because you lose control. And you might be selling your legacy. But let us pause here for a moment because I want to mention something real quick. If these conversations have moved your work forward in some small way, a handful of listeners chip in monthly through buy me a coffee dot com slash fexingo — that's F. E. X. I. N. G. O. — and that is literally what funds making this many of these episodes without ads. Luna: It is good to know the engine under the hood is actually fueled by the people listening. Thanks for keeping it ad-free. Lucas: Right. So back to the deal structure. The financing is usually debt-heavy. The DSO borrows against the future cash flows of the acquired practices. This is classic leveraged buyout logic applied to a service industry. Luna: But if interest rates stay high, that debt service eats into the margins they were counting on. How are they handling that pressure? Lucas: They are raising prices faster than inflation in many regions. You see crown and bridge fees jump ten percent year-over-year. It is a quiet tax on consumers that most patients don't even notice until they need major work. Luna: Which makes me wonder about the quality of care. Does adding layers of corporate management actually improve patient outcomes? Lucas: There is mixed data. Some studies show slightly higher compliance with preventive care because the DSO tracks metrics rigorously. Others suggest wait times increase because the doctors are capped at seeing a fixed number of patients per day to protect margins. Luna: So it is a trade-off between efficiency and accessibility. Which side do you think wins in the long run? Lucas: Efficiency always wins in private equity. The goal is not patient satisfaction scores; it is internal rate of return. They optimize for the exit, not the experience. Luna: That feels cynical, but it is probably accurate. What happens when a DSO tries to sell one of its portfolio companies? Lucas: They bundle them again. Or they spin off a smaller group to another financial buyer. It is a game of musical chairs where the music is interest rates and the chairs are cash-flowing practices. Luna: Are there any red flags for dentists thinking about selling? Like, what are the hidden traps in those purchase agreements? Lucas: Non-compete clauses are the biggest one. Many sellers find themselves barred from practicing within a fifty-mile radius for five years after the sale. That effectively kills their ability to restart an independent practice. Luna: That seems harsh. Is that enforceable everywhere? Lucas: Not anymore. Several states have limited non-competes for healthcare workers. But in many jurisdictions, they still hold water. Sellers need very sharp legal counsel before signing. Luna: Sharp counsel is expensive. Which brings us back to the economics. Are the margins really that thick? Lucas: They can be. Operating margins for top-tier DSOs sit around fifteen to eighteen percent. That is healthy, especially compared to the eight to ten percent net margin of a typical solo practice. Luna: So the DSO takes a cut, but saves enough on overhead to make the pie bigger overall? Lucas: Yes. Centralized billing reduces bad debt. Bulk purchasing cuts lab costs. Group purchasing organizations negotiate discounts that no single office could get. Luna: It sounds like a textbook economies of scale story. But does it feel sterile to the patient? Lucas: For many, it feels familiar. The waiting rooms look similar. The staff is trained to use the same software. It becomes a standardized brand, much like a hotel chain versus a boutique inn. Luna: I prefer the boutique inn myself. But I can see why convenience seekers prefer the chain. Lucas: Convenience is king. And the DSO model offers extended hours, multiple locations, and online booking. That frictionless experience drives volume. Luna: What about the dentists who stay independent? Are they getting squeezed out? Lucas: Some are. They struggle with administrative burdens. But others thrive by focusing on complex specialties that DSOs ignore. Implantology and orthodontics often remain independent because they require deep expertise and relationship building. Luna: So the market bifurcates. General dentistry goes corporate, specialty stays local. Lucas: That seems to be the trend. The generalists become assembly line operators, while specialists become consultants. Luna: Is there any pushback from regulators? It feels like anti-travel concerns are brewing. Lucas: State dental boards are watching closely. There have been hearings in California and New York about whether DSOs constitute corporate practice of medicine violations. Luna: Corporate practice of medicine laws vary by state. That must create a patchwork of compliance headaches. Lucas: It does. DSOs have to structure their ownership carefully to avoid violating these statutes. It adds legal complexity to an already heavy load. Luna: Do you think the pace of consolidation will slow down as the easy targets get bought up? Lucas: Eventually. But there are still thousands of solo practitioners approaching retirement age. That pipeline is vast. As long as there is money to be made, capital will flow in. Luna: And the next wave will likely target hygiene centers and oral surgery groups. The roll-up never stops. Lucas: Correct. It just changes shape. From teeth to gums to jaws. The asset class remains the same. Luna: It is fascinating how a profession rooted in individual craftsmanship has become a playground for algorithmic efficiency. Lucas: It forces us to ask whether healthcare should ever be fully optimized for profit. Or if some things resist the spreadsheet. Luna: Maybe the answer lies in letting patients vote with their wallets. If they hate the corporate feel, they will leave. Lucas: Or they will just accept higher prices for lower personal touch. It is a tough balance to strike. Luna: Let us hope the regulators keep a close eye on that trade-off before the last independent chair is sold. Lucas: Agreed. We will keep tracking the bids and the regulations. Until next time.